Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap
Indian Journal of Plastic Surgery · 01.10.2024 · 57 (05) · 379-386
DOI: 10.1055/s-0044-1785489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Plastic Surgery, erschienen am 01.10.2024. Verfasst von Prakash Chandra Kala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns and Plastic Surgery, All India Institute of Medical Science, Jodhpur, Rajasthan, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
The effect of the second wave of COVID-19 was immense in India, specifically in the form of vicious COVID-19-associated mucormycosis. A higher number of radical debridements are required for disease control in combination with antifungal drugs in cases of COVID-19-associated mucormycosis, which results in complex maxillofacial defects. We aimed to evaluate the clinical outcomes in patients with rhino-orbito-maxillary defects due to COVID-19-associated mucormycosis undergoing a single stage delayed free flap reconstruction. Methodology This prospective, single-center, multisurgeon study was performed on eight patients with COVID-19-associated rhino-orbito-maxillary mucormycosis in the department of burns and plastic surgery. The postoperative clinical outcome was evaluated using the University of Washington Quality of Life Questionnaire for patient's quality of life (QOL), aesthetic numeric analog (ANA) scale for patient's satisfaction for aesthetics, and the functional intraoral Glasgow scale for speech and deglutition at 1 and 3 months.
Results
The median age of the study patients was 40 years, with 75% of the patients being males. Diabetes mellitus (DM) was present in all the patients. Mucormycosis was diagnosed within the first 3 months of COVID-19 infection. Maxillary defect was present in 62.5% of patients, out of which 50% had bilateral maxillary defects. There was significant improvement in the QOL and the aesthetics of patients from 1 to 3 months (p < 0.001). Speech and deglutition were also improved at 3 months, but the difference was not statistically significant.
Conclusion
Single stage delayed free flap reconstruction can be advocated in patients with COVID-19-associated rhino-orbito-maxillary mucormycosis defect as there is considerable improvement in patients' QOL, aesthetics, speech, and deglutition over a period of time.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Burns and Plastic Surgery, All India Institute of Medical Science, Jodhpur, Rajasthan, India.
ORCID-Profile: Pawan Kumar Dixit, Deepti Katrolia, Shilpi Karmakar, Akhilesh Humnekar
Zitieren
APA
Kala, P. C., Dixit, P. K., Katrolia, D., Karmakar, S., Humnekar, A., Singla, P., & Singh, A. P. (2024). Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap. Indian Journal of Plastic Surgery, 57(05), 379-386. https://doi.org/10.1055/s-0044-1785489
Vancouver
Kala PC, Dixit PK, Katrolia D, Karmakar S, Humnekar A, Singla P, et al. Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap. Indian Journal of Plastic Surgery. 2024;57(05):379-386. doi:10.1055/s-0044-1785489
BibTeX
@article{Kala2024,
author = {Kala, Prakash Chandra and Dixit, Pawan Kumar and Katrolia, Deepti and Karmakar, Shilpi and Humnekar, Akhilesh and Singla, Priyanka and Singh, Apoorva Pratap},
title = {Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap},
journal = {Indian Journal of Plastic Surgery},
year = {2024},
volume = {57},
number = {05},
pages = {379--386},
doi = {10.1055/s-0044-1785489}
}
EUVIMED